Centessa Pharmaceuticals Stock Options
| CNTA Stock | USD 15.16 0.29 1.95% |
Centessa Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.39 with a put-to-call open interest ratio of 48.27 over 20 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Centessa Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Centessa Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Centessa Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Centessa Pharmaceuticals
Analyzing Centessa Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Centessa Pharmaceuticals regardless of its overall volatility. This is especially true when Centessa Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Centessa Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Centessa Pharmaceuticals' stock while costing only a fraction of its price.
Centessa Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Centessa Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Centessa stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Centessa Pharmaceuticals' stock price goes up or down, the stock options follow.
At present, Centessa Pharmaceuticals' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 17.6 M, whereas Total Stockholder Equity is forecasted to decline to about 232.1 M. Centessa Pharmaceuticals In The Money Call Balance
When Centessa Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Centessa Pharmaceuticals PLC stock is said to be in the money. When it comes to buying Centessa Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Centessa Pharmaceuticals PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Centessa Current Options Market Mood
Centessa Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Centessa Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Centessa Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Centessa Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Centessa contract
Base on the Rule 16, the options market is currently suggesting that Centessa Pharmaceuticals PLC will have an average daily up or down price movement of about 0.0869% per day over the life of the 2025-04-17 option contract. With Centessa Pharmaceuticals trading at USD 15.16, that is roughly USD 0.0132. If you think that the market is fully incorporating Centessa Pharmaceuticals' daily price movement you should consider buying Centessa Pharmaceuticals PLC options at the current volatility level of 1.39%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Centessa |
Purchasing Centessa Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Centessa calls. Remember, the seller must deliver Centessa Pharmaceuticals PLC stock to the call owner when a call is exercised.
Centessa Pharmaceuticals Option Chain
When Centessa Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Centessa Pharmaceuticals PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Centessa Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Centessa. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Centessa. It also shows strike prices and maturity days for a Centessa Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CNTA250417C00005000 | 0 | 5.0 | 8.5 - 13.0 | 8.5 | In |
Call | CNTA250417C00007500 | 0 | 7.5 | 6.0 - 10.5 | 6.0 | In |
Call | CNTA250417C00010000 | 0 | 10.0 | 4.1 - 8.5 | 4.1 | In |
Call | CNTA250417C00012500 | 5 | 12.5 | 2.2 - 6.5 | 7.22 | In |
Call | CNTA250417C00015000 | 6 | 15.0 | 1.0 - 5.0 | 4.0 | In |
Call | CNTA250417C00017500 | 4 | 17.5 | 1.0 - 5.0 | 2.75 | Out |
Call | CNTA250417C00020000 | 2 | 20.0 | 0.0 - 4.6 | 2.44 | Out |
Call | CNTA250417C00022500 | 2 | 22.5 | 0.0 - 4.9 | 2.3 | Out |
Call | CNTA250417C00025000 | 13 | 25.0 | 0.0 - 4.9 | 0.8 | Out |
Call | CNTA250417C00030000 | 1 | 30.0 | 0.0 - 4.9 | 0.55 | Out |
Put | CNTA250417P00005000 | 0 | 5.0 | 0.0 - 0.75 | 0.75 | |
Put | CNTA250417P00007500 | 1590 | 7.5 | 0.0 - 4.9 | 0.4 | Out |
Put | CNTA250417P00010000 | 1 | 10.0 | 0.0 - 4.9 | 1.15 | Out |
Put | CNTA250417P00012500 | 1 | 12.5 | 0.0 - 4.9 | 1.8 | Out |
Put | CNTA250417P00015000 | 1 | 15.0 | 1.0 - 5.0 | 1.0 | Out |
Put | CNTA250417P00017500 | 0 | 17.5 | 2.0 - 6.0 | 2.0 | In |
Put | CNTA250417P00020000 | 0 | 20.0 | 4.0 - 8.0 | 4.0 | In |
Put | CNTA250417P00022500 | 0 | 22.5 | 6.0 - 10.0 | 6.0 | In |
Put | CNTA250417P00025000 | 0 | 25.0 | 8.0 - 12.5 | 8.0 | In |
Put | CNTA250417P00030000 | 0 | 30.0 | 13.2 - 17.5 | 13.2 | In |
Centessa Total Stockholder Equity
Total Stockholder Equity |
|
Centessa Pharmaceuticals Corporate Management
| Tia Bush | Chief Officer | Profile | |
| Ellie MD | Senior Oncology | Profile | |
| MD MSc | Ex Devel | Profile | |
| April Dovholuk | Senior Operations | Profile | |
| JD Esq | Senior Communications | Profile | |
| MBA MD | Principal CFO | Profile | |
| David Chao | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.